CVI Holdings’s TriSalus Life Sciences TLSI Stock Holding History

CVI Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-299,993	Closed	-$2.98M	–	643
2022 Q3	$2.98M	Hold	299,993	–	–	0.23%	157
2022 Q2	$2.95M	Hold	299,993	–	–	0.21%	172
2022 Q1	$2.94M	Buy	299,993 +5,057	+2%	+$49.9K	0.19%	190
2021 Q4	$2.91M	Buy	294,936 +13,896	+5%	+$138K	0.19%	183
2021 Q3	$2.79M	Buy	281,040 +31,040	+12%	+$304K	0.17%	207
2021 Q2	$2.42M	Hold	250,000	–	–	0.16%	206
2021 Q1	$2.42M	Buy	+250,000	New	+$2.54M	0.17%	199

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CVI Holdings's TLSI Position: Q4 2022 in Review

CVI Holdings sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 299,993 shares — an estimated $2.98M sold.

CVI Holdings first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $2.98M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

CVI Holdings reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 299,993 TriSalus Life Sciences shares in Q4 2022, an estimated $2.98M.
CVI Holdings first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
CVI Holdings's TriSalus Life Sciences position peaked at $2.98M in Q3 2022.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.